The New York Times: Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

Iniciado por FeedBot, Jun 10, 2024, 07:23 PM

Tema anterior - Siguiente tema
Imprimir
Ir Abajo Páginas1
Acciones del Usuario

FeedBot

Jun 10, 2024, 07:23 PM
Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer's Drug

The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

Source: Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer's Drug
Imprimir
Ir Arriba Páginas1
Acciones del Usuario